Maximal neutropenia during chemotherapy and radiotherapy is significantly associated with the development of acute radiation-induced dysphagia in lung cancer patients

Annals of Oncology

Volumn 18, Issue 5, 2007, Pages 909-916

  De Ruysscher, Dirk ^a   Dehing, C ^a   Bremer, R H ^a   Bentzen, S M ^b   Koppe, F ^a   Pijls Johannesma, M ^a   Harzee L ^c   Minken, A ^a   Wanders, R ^a   Hochstenbag, M ^a   Dingemans, A M ^a   Boersma, L ^a   van Haren, E ^d   Geraedts, W ^d   Pitz, C ^e   Simons, J ^f   Wouters, B G ^a   Rosier, J F ^c   Lambin, P ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^c Hospital de Jolimont   (Belgium)

^d Sittard Geleen Heerlen   (Netherlands)

^e LAURENTIUS HOSPITAL   (Netherlands)

^f Department of Pulmonology   (Netherlands)

Author keywords

Chemotherapy; Esophagitis; Lung cancer; Neutropenia; Predictive factors; Radiotherapy

Indexed keywords

CARBOPLATIN; CISPLATIN; ETOPOSIDE; GEMCITABINE;

ACUTE DISEASE; ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DYSPHAGIA; FEMALE; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; NEUTROPENIA; PATIENT CODING; PREDICTION; PREDICTOR VARIABLE; PRIORITY JOURNAL; RADIATION SICKNESS; REGRESSION ANALYSIS; RISK ASSESSMENT;

ACUTE DISEASE; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SMALL CELL; COMBINED MODALITY THERAPY; DEGLUTITION DISORDERS; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEUTROPENIA; RADIATION INJURIES; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES;

EID: 34447319112     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdm005     Document Type: Article

References (29)

1. Curran WJ, Scott CB, Langer CJ et al. Long-term benefit is observed in a phase III comparison of sequential vs concurrent chemoradiation for patients with unresected stage III NSCLC: RTOG 9410. Proc Am Soc Clin Oncol 2003; 22: 621.
2. Fournel P, Robinet G, Perol M et al. Randomized phase III trial of sequential chemoradiotherapy compared with concurrent chemoradiotherapy in locally advanced non-small-cell lung cancer: Groupe Lyon-Saint-Etienne d'Oncologie Thoracique-Groupe Francais de Pneumo-Cancerologie NPC 95-01 Study. J Clin Oncol 2005; 23: 5910-5917.
3. Furuse K, Fukuoka M, Kawahara M et al. Phase III study of concurrent versus sequential radiotherapy in combination with mitomycin, vindesine and cisplatin in unresectable stage III non-small cell lung cancer. J Clin Oncol 1999; 17: 2692-2699.
4. Zatloukal P, Petruzelka L, Zemanova M et al. Concurrent versus sequential chemoradiotherapy with cisplatin and vinorelbine in locally advanced non-small cell lung cancer: A randomized study. Lung Cancer 2004; 46: 87-98.
5. Takada M, Fukuoka M, Kawahara M et al. Phase III study of concurrent versus sequential thoracic radiotherapy in combination with cisplatin and etoposide for limited-stage small-cell lung cancer: Results of the Japan Clinical Oncology Group Study 9104. J Clin Oncol 2002; 20: 3054-3060.
6. Murray N, Coy P, Pater JL et al. Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small-cell lung cancer. The National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol 1993; 11: 336-344.
7. De Ruysscher D, Pijls-Johannesma M, Bentzen SM et al. The time between the first day of chemotherapy and the last day of chest radiation is the most important predictor of survival in limited disease small cell lung cancer. J Clin Oncol 2006; 24: 1057-1063.
8. De Ruysscher D, Pijls-Johannesma M, Vansteenkiste J et al. Systematic review and meta-analysis of randomised controlled trials of timing of chest radiotherapy in patients with limited stage small cell lung cancer. Ann Oncol 2006; 17: 543-552.
9. Turrisi AT, Kim K, Blum R et al. Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide. N Engl J Med 1999; 340: 265-271.
10. Bentzen SM. Preventing or reducing late side effects of radiation therapy: Radiobiology meets molecular pathology. Nat Rev Cancer 2006; 6: 702-713.
11. Hirota S, Tsujino K, Endo M et al. Dosimetric predictors of radiation esophagitis in patients treated for non-small lung cancer with carboplatin/paclitaxel/radiotherapy. Int J Radiat Oncol Biol Phys 2001; 51: 291-295.
12. Maguire PD, Sibley GS, Zhou S et al. Clinical and dosimetric predictors of radiation-induced esophageal toxicity. Int J Radiat Oncol Biol Phys 1999; 45: 97-103.
13. Werner-Wasik M, Pequinot E, Leeper D et al. Predictors of severe esophagitis include use of concurrent chemotherapy, but not length of irradiated esophagus: A multivariate analysis of patients with lung cancer treated with nonoperative therapy. Int J Radiat Oncol Biol Phys 2000; 48: 689-696.
14. Bradley J, Deasy JO, Bentzen SM et al. Dosimetric correlates for acute esophagitis in patients treated with radiotherapy for lung carcinoma. Int J Radiat Oncol Biol Phys 2004; 58: 1106-1113.
15. Belderbos J, Heemsbergen W, Hoogeman M et al. Acute esophageal toxicity in non-smal cell lung cancer patients after high dose conformal radiotherapy. Radiother Oncol 2005; 75: 157-164.
16. Chapet O, Kong FM, Lee JS et al. Normal tissue complication probability modeling for acute esophagitis in patients treated with conformal radiation therapy for non-small cell lung cancer. Radiother Oncol 2005; 77: 176-181.
17. Wei X, Liu HH, Tucker SL et al. Risk factors for acute esophagitis in non-small-cell lung cancer patients treated with concurrent chemotherapy and three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys 2006; 66: 100-107.
18. Patel AB, Edelman MJ, Kwok Y et al. Predictors of acute esophagitis in patients with non small cell lung carcinoma treated with concurrent chemotherapy and hyperfractionated radiotherapy followed by surgery. Int J Radiat Oncol Biol Phys 2004; 60: 1106-1112.
19. Qiao WB, Zhao YH, Zhao YB et al. Clinical and dosimetric factors of radiation-induced esophageal injury: Radiation-induced esophageal toxicity. World J Gastroenterol 2005; 11: 2626-2629.
20. Singh AK, Lockett M, Bradley JD. Predictors of radiation-induced esophageal toxicity in patients with non-small-cell lung cancer treated with three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys 2003; 55: 337-341.
21. Senan S, De Ruysscher D, Giraud P et al. Literature-based recommendations for treatment planning and execution for high-precision radiotherapy in lung cancer. Radiother Oncol 2004; 71: 139-146.
22. ICRU Report 50. Prescribing, Recording, and reporting Photon Beam Therapy. International Commission on Radiation Units and Measurements. Oxford, UK: Oxford University Press 1993.
23. Hendry JH, Bentzen SM, Dale RG et al. A modelled comparison of the effects of using different ways to compensate for missed treatment days in radiotherapy. Clin Oncol (R Coll Radiol) 1996; 8: 297-307.
24. Bentzen SM, Dorr W, Anscher MS et al. Normal tissue effects: Reporting and analysis. Semin Radiat Oncol 2004; 13: 189-202.
25. Bentzen SM, Saunders MI, Dische S et al. Radiotherapy-related early morbidity in head and neck cancer: Quantitative clinical radiobiology as deduced from the CHART trial. Radiother Oncol 2001; 60: 123-135.
26. Bentzen SM, Saunders MI, Dische S, From CHART to CHARTWEL in non-small cell lung cancer: Clinical radiobiological modelling of the expected change in outcome. Clin Oncol (R Coll Radiol) 2002; 14: 372-381.
27. Kishi S, Yang W, Boureau B et al. Effects of prednisone and genetic polymorphisms on etoposide disposition in children with acute lymphoblastic leukemia. Blood 2004; 103: 67-72.
28. Epperly MW, Shen H, Jefferson M et al. In vitro differentiation capacity of esophageal progenitor cells with capacity for homing and repopulation of the ionizing irradiation-damaged esophagus. In Vivo 2004; 18: 675-685.
29. Epperly MW, Guo H, Shen H et al. Bone marrow origin of cells with capacity for homing and differentiation to esophageal squamous epithelium. Radiat Res 2004; 162: 233-240.